Loading organizations...
§ Venture Capital · Tokyo, Japan
Toranomon Impact Capital is an investment firm.
Toranomon Impact Capital is a venture capital firm based in Tokyo, Japan. The firm specializes in impact investments, with a particular focus on the health sector. It operates the Tokyo Wellness Impact Investment Business Limited Liability Partnership, aligning its investment activities with its mission to support advancements in health-related initiatives.
Established jointly by Monex Ventures, Toranomon Impact Capital engages in venture funding rounds, including seed and Series A investments. Its portfolio includes companies such as HEALTHREE, Inc., Eight Lab Inc., Vreach, and MELON, reflecting its commitment to fostering innovation within the health and wellness ecosystem.
Toranomon Impact Capital was established jointly by Monex Ventures, indicating a collaborative foundation within the Japanese investment landscape.
Toranomon Impact Capital was established jointly by Monex Ventures, indicating a collaborative foundation within the Japanese investment landscape.
Toranomon Impact Capital has 1 tracked investment across 1 company. The latest tracked deal is lll - Series A in HEAL-lll in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 12, 2026 | HEAL-lll | lll - Series A | — | Akinori Harada, Capital Medica Ventures, JP Life Next Fund, Koseki, Monex Ventures, Takehiro Goda |
Toranomon Impact Capital is a venture capital firm operating from Tokyo, Japan, with a dedicated focus on impact investments within the health sector. The firm was established through a joint effort involving Monex Ventures, positioning it within the broader Japanese venture ecosystem. Its investment strategy is centered on identifying and supporting companies that aim to create positive societal impact, particularly in areas related to health and wellness.
The firm's operational structure includes the Tokyo Wellness Impact Investment Business Limited Liability Partnership, which serves as a vehicle for its investment activities. This partnership model underscores Toranomon Impact Capital's specialized approach to funding, ensuring that its capital deployment is aligned with its impact-oriented objectives. The firm participates in various stages of venture funding, from seed rounds to Series A investments.
Toranomon Impact Capital has made several notable investments in companies developing solutions within the health and wellness domain. For instance, it participated in the Series A funding round for HEALTHREE, Inc. in February 2026, alongside Kyoeki Co., Ltd. and Kanpo Next Partners. This investment highlights the firm's interest in growth-stage companies that are poised for significant development.
Further demonstrating its investment scope, Toranomon Impact Capital provided venture funding to Eight Lab Inc. in May 2025. The firm also contributed to the seed round for Vreach and was an investor in MELON's Series A funding round, which included JPY450 million in capital and co-investors such as SMBC Venture Capital. These examples illustrate the firm's active role in supporting early to mid-stage companies that are innovating within the health sector.